A Phase 3 study comparing Samsung Bioepis' SB8 with Avastin in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC) demonstrated equivalent efficacy in terms of risk ratio of overall response rate (ORR).
It is always advisable to detect and treat early signs of skin cancer as it helps to diminish the chances of surgery, disfigurement or death. Talking to a specialist is always advisable in order to discuss the potential risk of skin cancer.